Invisible disabilities and discrimination
Blog
PLATINUM Award for RARE-e-CONNECT at the Cyprus Healthcare Business Awards
RARE-e-CONNECT at the European Conference on Rare Diseases and Orphan Drugs ECRD 2022
RARE-e-CONNECT on IRDiRC's State of Play - Stimulating multistakeholder engagement
Trial gene therapy for Duchenne Muscular Dystrophy
Duchenne, GeneTherapy, Neuromuscular Diseases , RareDiseases, DuchenneMuscularDystrophy
Patient experience: LAM disease, work and life
Invisible disabilities, Rare diseases at work, LAM disease, Lymphangioleiomyomatosis
Patient experiences at the work market: Myasthenia Gravis
Invisible disabilities, Myasthenia Gravis, Rare diseases at work
More Articles ...
The Project POST-DOC/0916/0222 is co-financed by the European Regional Development Fund and the Republic of Cyprus through the Research and Innovation Foundation. The Host Organisation is Cyprus Alliance for Rare Disorders.